NCT02128321View on ClinicalTrials.gov

A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Repaglinide and Caffeine

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Pharmacokinetics of RepaglinidePharmacokinetics of CaffeineHealthy Subjects
Interventions
DRUG

Isavuconazole

oral

DRUG

Repaglinide

oral

DRUG

Caffeine

oral

Trial Locations (1)

21225

Parexel Early Phase Clinical Unit, Baltimore

Sponsors
All Listed Sponsors
collaborator

Basilea Pharmaceutica International Ltd

INDUSTRY

lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT02128321 - A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Repaglinide and Caffeine | Biotech Hunter | Biotech Hunter